# A Two-part Study to Investigate the Effects in Adults of Two Doses of Golexanolone in Patients With Primary Biliary Cholangitis (PBC) With Fatigue and Cognitive Dysfunction

> clinical trial · VERIFIED · 2026-08-28

Status: ACTIVE_NOT_RECRUITING · Sponsor: Umecrine Cognition AB · Condition: Primary Biliary Cholangitis (PBC)

- Company: Umecrine Cognition AB
- Sector: therapeutics
- Primary source: https://clinicaltrials.gov/study/NCT07304843

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.